Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression
J Clin Psychopharmacol
.
2023 Sep-Oct;43(5):462-464.
doi: 10.1097/JCP.0000000000001726.
Epub 2023 Jun 23.
Authors
Juliana Zambrano
1
,
Fernando Espi Forcen
Affiliation
1
Department of Psychiatry, Massachusetts General Hospital; and Harvard Medical School, Boston, MA jzambrano2@mgh.harvard.edu .
PMID:
37683239
DOI:
10.1097/JCP.0000000000001726
No abstract available
MeSH terms
Administration, Intravenous
Depression
Depressive Disorder, Treatment-Resistant*
Humans
Ketamine* / therapeutic use
Psychotherapy
Stress Disorders, Post-Traumatic* / drug therapy
Substances
Ketamine